A

Abzena

CDMO for complex biologics and ADCs

Raw Material Sampling Coordinator

Full-TimeUpdated on 10/22/2026
No salary listed
Junior
Bachelor's, Associate's
Bristol, PA, USA
In PersonTravel between Abzena sites in Bristol, PA; San Diego, CA; and Cambridge, UK as needed.
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A high school diploma or equivalent is required.
  • A minimum of two years of experience in pharmaceutical, biotechnology, laboratory, warehouse, materials management, or other regulated operations is preferred; direct GMP raw material sampling experience is strongly preferred.
  • Working knowledge of current Good Manufacturing Practice requirements, good documentation practices, material status control, traceability, chain of custody, and contamination prevention.
  • Ability to follow material specifications, sampling plans, standard operating procedures, safety data sheets, and written work instructions accurately.
  • Strong attention to detail and ability to maintain accurate, contemporaneous, and traceable GMP documentation.
  • Ability to identify discrepancies, stop work when conditions are unacceptable, and promptly escalate quality, safety, or material integrity concerns.
  • Organizational, communication, and collaboration skills to manage changing priorities and coordinate with Quality Control and Materials Management.
  • Ability to work independently after qualification and provide flexible coverage to support material receipts, Quality Control testing schedules, and manufacturing readiness.
  • Ability to stand for one to two hours at a time and sit for two to three hours at a time.
  • Frequently lift or move objects weighing at least 15 pounds and occasionally lift or move heavier materials with appropriate assistance or equipment.
  • Ability to handle and manipulate sampling tools and perform detailed labeling and documentation activities, and to climb, balance, stoop, kneel, crouch, or reach as needed.
  • Visual abilities including near and far sight, color recognition, peripheral vision, depth perception, and the ability to focus.
  • Ability to wear required personal protective equipment, including gowning and respiratory protection when applicable.
Responsibilities
  • Support compliance with 21 CFR, current Good Manufacturing Practice regulations, the company's Quality Management System, standard operating procedures, approved material specifications, sampling plans, and company policies.
  • Review incoming material receipt documentation, material status, lot information, container counts, and sampling requirements before sampling.
  • Coordinate daily raw material sampling priorities with Materials Management, Quality Control, Supply Chain, and Manufacturing to support material release and manufacturing readiness.
  • Inspect incoming material containers for identity, labeling, seal integrity, damage, cleanliness, and other visible conditions affecting quality or sampling suitability, and escalate discrepancies before sampling.
  • Stage and move quarantined raw materials into approved sampling locations while maintaining status segregation, traceability, environmental conditions, and handling controls.
  • Perform representative raw material sampling using approved procedures, sampling tools, qualified equipment, and required personal protective equipment while minimizing contamination, cross-contamination, and exposure risk.
  • Perform aseptic or controlled sampling in a biological safety cabinet, sampling booth, or other qualified area when required by the material, specification, or procedure.
  • Label sample containers and document sample identity, material code, supplier lot, internal lot, quantity, sampling date, sampler identification, and other required traceability information.
  • Maintain sample chain of custody from collection through handoff to Quality Control or an approved external testing laboratory, including timely delivery under required storage or temperature conditions.
  • Complete required enterprise resource planning, inventory, laboratory information management system, logbook, and controlled documentation transactions accurately and contemporaneously in accordance with data integrity and good documentation practices.
  • Reseal and relabel sampled source containers as required, and return them to the correct quarantine or controlled storage location while maintaining material status.
  • Support retain sample activities, sample reconciliation, sample inventory, and disposition activities when assigned.
  • Clean, sanitize, and maintain sampling areas, equipment, tools, and supplies in inspection-ready condition according to approved procedures.
  • Monitor availability of sampling consumables, personal protective equipment, labels, containers, and equipment, and escalate shortages or equipment issues that could delay sampling or Quality Control testing.
  • Initiate or support deviations, investigations, corrective and preventive actions, change controls, and other quality records related to sampling errors, damaged materials, documentation discrepancies, environmental concerns, or procedural nonconformance.
  • Support internal audits, client audits, and regulatory inspections by providing sampling records, demonstrating approved processes, and maintaining inspection-ready areas and documentation.
  • Participate in continuous improvement activities focused on sampling turnaround time, right-first-time documentation, sample traceability, material flow, safety, and operational efficiency.
  • Provide task-specific training and practical guidance to qualified personnel on approved raw material sampling practices when assigned.
  • Perform other duties as assigned to support business and operational needs.
  • Travel between company sites in Bristol, Pennsylvania; San Diego, California; and Cambridge, United Kingdom as needed.
Desired Qualifications
  • An associate's or bachelor's degree in Chemistry, Biology, Pharmaceutical Sciences, Life Sciences, Supply Chain, or a related field is preferred.
  • Hands-on experience with raw material sampling tools, balances, sampling booths, biological safety cabinets, or controlled sampling environments is preferred.
  • Experience with enterprise resource planning/materials requirements planning and/or laboratory information management systems is preferred; experience with IFS, SAP, or equivalent systems is a plus.
  • Experience handling temperature-sensitive, hazardous, or controlled raw materials is preferred, including use of required personal protective equipment and compliance with site environmental, health, and safety requirements.
  • Forklift or powered industrial truck certification is preferred where material movement is part of assigned duties, or the ability to obtain certification.

About the company

Abzena is a CDMO that provides integrated services for complex biologics and bioconjugates, including antibody-drug conjugates (ADCs). It supports projects from antibody discovery through GMP manufacturing for clinical trials and commercial supply, using its in-house platforms and expertise. It differentiates itself with end-to-end development and manufacturing capabilities, supported by proprietary technologies like ThioBridge and Composite Human Antibody, and global facilities in San Diego, Bristol, and Cambridge. Its goal is to help biologics programs progress efficiently from discovery to market by offering specialized, partnered development and manufacturing services and potential licensing of its technologies.

Company Size

201-500

Company Stage

IPO

Headquarters

Babraham, United Kingdom

Founded

2001

Get referred to Abzena

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 2026 Frost recognized Abzena as an ADC CDMO leader.
  • September 2025 GS knockout CHO-K1 platforms expanded AbzelectPRO capabilities.
  • 2026 AOC momentum, including Novartis-Avidity and Dyne, lifts demand for integrated services.

What critics are saying

  • Headcount fell 6.4% from 2023 to March 2026, signaling operational tightening.
  • WCAS ownership creates exit pressure, distracting management from long-term customer retention.
  • Large pharma can internalize ADC manufacturing, leaving Abzena dependent on fragile biotech demand.

What makes Abzena unique

  • Abzena spans discovery, conjugation, and GMP manufacturing across San Diego, Bristol, and Cambridge.
  • ThioBridge and integrated ADC expertise distinguish Abzena in complex bioconjugates.
  • Its 2026 Frost Radar leadership validates specialization in ADCs and AOCs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget

Growth & Insights and Company News

6 month growth

1%

1 year growth

-1%

2 year growth

0%
Abzena
Jul 15th, 2026
Outsourced Pharma capability Update - Cell Line Development June 2026.

Outsourced Pharma capability Update - Cell Line Development June 2026. Early cell line decisions define everything that comes after: yield, stability, manufacturability, and timelines. That's why Abzena PLC presented at the Outsourced Pharma Capabilities Update on June 16th, which is focused on Cell Line Development strategies. Abzena's VP & Scientific Leader of Cell Line Development, John E. Gill IV, presented a talk on "Integrated Cell Line Development: Manufacturability to GMP-Ready by Design." John broke down how a truly integrated approach, one built with GMP readiness and manufacturability in mind from day one, changes the trajectory of complex biologic programs. The result: - Accelerated timelines to GMP - Reduced downstream risk - Cell lines engineered to meet GMP standards, not retrofitted to them - A smoother, faster path from discovery to clinical & commercial manufacturing When GMP readiness is designed in from the start, not added later, programs don't stall. They move forward faster.

Abzena
Mar 17th, 2026
Frost radar report: Antibody-Drug Conjugate contract development & manufacturing organizations.

Frost radar report: Antibody-Drug Conjugate contract development & manufacturing organizations. Abzena is recognized as a technology-forward, innovative CDMO in the Frost radar(tm): ADC contract development and manufacturing report, 2025. In this comprehensive analysis of the Antibody-Drug Conjugate (ADC) contract development and manufacturing (CDMO) market, global research analysts Frost & Sullivan, an independent firm, evaluated leading service providers and recognized Abzena as a Leader in both Innovation and Growth. As the author of the report, Unmesh Lal, VP of Healthcare & Life Sciences at Frost & Sullivan, shared, "With deep analytical expertise, flexible licensing models, and a dual US-UK footprint, Abzena combines scientific rigor with commercial agility. Its 'grow-with-the-client' strategy is converting early-stage partnerships into long-term manufacturing relationships, solidifying its position as a premier end-to-end CDMO for complex biologics." * How Abzena's proprietary ThioBridge(R) site-specific conjugation platform improves the design & delivery of ADCs. * How a fully integrated end-to-end development and manufacturing model eliminates tech-transfer risks and reduces timelines & costs. * How assay development for complex ADC & AOC characterization provides the data needed to de-risk clinical programs & build confidence with regulators and investors * How a dual US and UK integrated footprint provides a secure supply chain and deep FDA and EMA regulatory expertise.

Clinical Research News
Sep 16th, 2025
Abzena Enhances AbZelectPRO(TM) Cell Line Offering with New GS Knockout Platforms

Abzena enhances abzelectpro(tm) cell line offering with new GS knockout platforms san diego, CA - september 15, 2025 - abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its abzelectpro(tm) cell line development (CLD) platform with the launch of two next-generation glutamine synthetase ("GS") knockout CHO-K1 expression systems, including a double knockout ADCC+ platform for afucosylated proteins.

Bio-IT World
Jul 22nd, 2025
Appointment; Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

San Diego, CA - July 22, 2025 - Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, today announced that Geoffrey M. Glass has been appointed Chief Executive Officer (CEO), effective immediately.

PR Newswire
May 15th, 2025
Abzena Announces Establishment Of Scientific Advisory Board To Support Innovation Strategy

SAN DIEGO, May 15, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has announced today the formation of its Scientific Advisory Board (SAB) comprised of biopharma industry experts with diversified expertise in Discovery Research & Development (R&D) and Chemistry, Manufacturing, and Controls (CMC). The new advisory board will work closely with Abzena's scientific and commercial leadership to provide strategic guidance and expert insights that support Abzena's continued commitment to growth and innovation.Matt Stober, CEO of Abzena, said, "The establishment of the Scientific Advisory Board was a strategic decision to help guide the future of Abzena. We have seen considerable momentum over the past few years in supporting complex and innovative modalities, such as Antibody-drug conjugates (ADCs), Antibody-oligonucleotide conjugates (AOCs), and bispecifics. We aim to continue building upon this by offering the most state-of-the-art technologies and capabilities to support our customers' programs. These experts will be instrumental in assisting us with this mission by evaluating our strategies and providing recommendations that will further enhance our ability to move medicines forward to patients faster."Joe Principe, CCO of Abzena, said, "We are honored to welcome these distinguished individuals to our Scientific Advisory Board. These founding members are recognized leaders in our industry, bringing a wealth of expertise that will help guide us as we continue through this significant phase of our growth